Medicure IncOTC Pink - Current Information:MCUJFView on Canadian Exchange
- LAST PRICE0.6797
- TODAY'S CHANGE (%)-0.0403 (-5.5972%)
- Bid / Lots0.6904/ 20
- Ask / Lots0.8768/ 100
- Open / Previous Close0.6797 / 0.7200
- Day Range
- 52 Week Range
- Volume100
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MCUJF |
|---|---|---|
| 09:32 ET | 100 | 0.6797 |
Apr 8, 2024
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023, from 5:02PM ET on Monday Apr 08, 2024 by Dow Jones
5:02PM ET on Monday Apr 08, 2024 by Dow Jones
Apr 4, 2024
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023, from 6:02PM ET on Thursday Apr 04, 2024 by Dow Jones
6:02PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medicure Inc | 10.3M | -10.4x | --- |
TRACON Pharmaceuticals Inc | 4.1M | -0.4x | --- |
PhaseBio Pharmaceuticals Inc | 50.0 | 0.0x | --- |
Todos Medical Ltd | 2.1K | 0.0x | --- |
Pear Therapeutics Inc | 140.0 | 0.0x | --- |
Rosetta Genomics Ltd | 590.0 | 0.0x | --- |
Company Information
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Contact Information
- Headquarters
- 1250 Waverley StreetWINNIPEG, MB, Canada R3T 6C6
- Phone
- 204-487-7412
- Fax
- 204-487-7412
Executives
- Chairman of the Board, Chief Executive Officer
- Albert Friesen
- President, Chief Operating Officer
- Neil Owens
- Chief Financial Officer
- Haaris Uddin
- Director
- James Kinley
- Independent Director
- Brent Fawkes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.5M |
|---|---|
Revenue (TTM) | $15.8M |
Shares Outstanding | 10.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-0.07 |
Book Value | $1.39 |
P/E Ratio | -10.4x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | 8.3x |
Operating Margin | -3.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
